Nikhil Lalwani sold $383k of ANIP
PRESIDENT & CEO at ANI PHARMACEUTICALS INC. 5,400 shares at an average of $71.00, traded Sep 15, 2026, filed Sep 16, 2026.
Score components
- +25RoleCEO
- +16Trade size$383k at market
- 0Share of holdings soldSold 1.6% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001822629-26-000016, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | SOpen-market sale Common Stock10b5-1 | -5,400 | $71.00 | $383k | 339,089 | 26 d ago |
Related signals
Other insiders at ANI PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $208k 2,850 shares | -2% | |
| 18Weak | ANI PHARMACEUTICALS INC | Jeanne Thoma director | $72k 1,000 shares | -4% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $35k 500 shares | -1% | |
| 29Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $207k 2,850 shares | -2% | |
| 13Weak | ANI PHARMACEUTICALS INC | Krista Davis SVP, CHIEF HR OFFICER | $98k 1,000 shares | -2% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $39k 400 shares | -1% | |
| 56Moderate | ANI PHARMACEUTICALS INC | Antonio R Pera director | $692k 7,292 shares | -24% | |
| 53Moderate | ANI PHARMACEUTICALS INC | Matthew J Leonard director | $229k 2,528 shares | -27% | |
| 41Moderate | ANI PHARMACEUTICALS INC | Krista Davis SVP, CHIEF HR OFFICER | $161k 1,763 shares | -3% | |
| 65Notable | ANI PHARMACEUTICALS INC | Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS | $9.0M 100,000 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.